Back to Markets
PTPTC Therapeutics Inc

PTC Therapeutics Inc

PTCTNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$68.23

-5.570000 (-7.55%)

As of 06/02/26 EDT · USD

Compare
Low: $43.18Current: $68.23High: $87.50

Key Statistics

Open

Day High

Day Low

Prev. Close

$68.23

VolumeShares traded today.

1.19M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$5.66B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-29.53

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$87.50

52W LowLowest price over the past 52 weeks.

$43.18

50D MAAverage closing price over the last 50 trading days.

$69.53

200D MAAverage closing price over the last 200 trading days.

$68.84

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+0.9%

1M

+4.7%

6M

-20.7%

YTD

-11.1%

1Y

+39.7%

About

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

www.ptcbio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade PTCT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.